in the PR yesterday it states that the ownership of the jv is largely unchanged and becoming a licensing entity. What exactly does that mean to you?
It means the joint venture, SCRMI, remains 60%/CHA and ACT/40% and that SCRMI is no longer a research company but a licensing company, to issue licenses for hemangioblast technoplogy.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.